Lansoprazolo Fg

Lansoprazole, the active ingredient in Lansoprazolo Fg, is a proton pump inhibitor presented as an oral formulation for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, and erosive esophagitis in adults.

GNH USA supplies Lansoprazolo Fg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that reduces gastric acid production in several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations. - Erosive esophagitis: promotes mucosal repair and reduces further damage.

Adverse reactions may occur with lansoprazole therapy.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be transient. - Nausea: feeling of queasiness, sometimes accompanied by vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Liver enzyme elevation: signs of hepatic stress detectable in blood tests. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following precautions.

- Renal impairment: assess kidney function and adjust dose if severe. - Hepatic disease: use with caution in patients with liver dysfunction. - Long‑term use: monitor for increased risk of bone fractures and vitamin B12 deficiency. - Known hypersensitivity: avoid in individuals with documented allergy to lansoprazole or related compounds. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may interact with several medicines.

Major Interactions (Avoid): - Atazanavir: reduced absorption leading to sub‑therapeutic levels. - Nelfinavir: decreased antiviral efficacy due to lowered gastric acidity. - Rilpivirine: diminished exposure compromising HIV treatment.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced activation may lessen antiplatelet effect. - Warfarin: potential increase in INR requiring closer monitoring. - Digoxin: elevated serum concentrations may increase risk of toxicity.